Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colchicine or Prednisone for the Treatment of Acute Calcium Pyrophosphate Deposition (CPPD) Arthritis: Open-label, Randomized, Multicenter, Equivalence Trial of Efficacy and Safety

NCT03128905 is registered in ClinicalTrials.gov with Lille Catholic University as lead sponsor.

NCT NCT03128905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03128905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colchicine or Prednisone for the Treatment of Acute Calcium Pyrophosphate Deposition (CPPD) Arthritis: Open-label, Randomized, Multicenter, Equivalence Trial of Efficacy and Safety
Lead sponsor
Lille Catholic University
Phase
Phase 3
Overall status
Completed
Start date
February 5, 2018
Completion date
May 13, 2022
Enrollment
111 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

chondrocalcinosis